Ignite Creation Date:
2024-05-06 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05793307
Status:
RECRUITING
Last Update Posted:
2023-06-06
First Post:
2023-03-20
Brief Title:
Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug
Sponsor:
GeneCradle Inc
Organization:
GeneCradle Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pompe Disease Infantile-Onset |
Keywords: